NDC 68462-295 – Trandolapril and Verapamil Hydrochloride
Trandolapril 2 mg/1; Verapamil Hydrochloride 180 mg/1 · Tablet, Film Coated, Extended Release · Oral
Product NDC68462-295
Product details
- Brand name
- Trandolapril and Verapamil Hydrochloride
- Generic name
- Trandolapril and Verapamil Hydrochloride
- Labeler
- Glenmark Pharmaceuticals Inc., USA
- Dosage form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA079135
- Marketed since
- February 25, 2015
- Listing expires
- December 31, 2027
- Pharmacologic class
- Angiotensin Converting Enzyme Inhibitor; Calcium Channel Blocker
Active ingredients
- Trandolapril 2 mg/1
- Verapamil Hydrochloride 180 mg/1
Uses, dosage, side effects and warnings for Trandolapril and Verapamil Hydrochloride →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 68462-295-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-01) | Feb 25, 2015 |
| 68462-295-10 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-10) | Feb 25, 2015 |
| 68462-295-90 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-295-90) | Feb 25, 2015 |
Recalls mentioning this NDC
- D-1095-2023 Aug 30, 2023 · Class III
Subpotent: Out of Specification for Assay Test at the 3-month time point.
Other Trandolapril and Verapamil Hydrochloride products
- 68462-294 Trandolapril 1 mg/1; Verapamil Hydrochloride 240 mg/1 · Tablet, Film Coated, Extended Release · Glenmark Pharmaceuticals Inc., USA
- 68462-296 Trandolapril 2 mg/1; Verapamil Hydrochloride 240 mg/1 · Tablet, Film Coated, Extended Release · Glenmark Pharmaceuticals Inc., USA
- 68462-329 Trandolapril 4 mg/1; Verapamil Hydrochloride 240 mg/1 · Tablet, Film Coated, Extended Release · Glenmark Pharmaceuticals Inc., USA